Quick Answer
ABVC BIOPHARMA, INC. reported Cash And Cash Equivalents At Carrying Value of $681.5 thousand for the year ending 2025.
- ABVC BIOPHARMA, INC. showed an increase of +174.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ABVC BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2010 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2010 to 2025), ABVC BIOPHARMA, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 24,117.5%.
- Historical annual values: Fiscal year 2025: $681.5 thousand | Fiscal year 2024: $248.4 thousand | Fiscal year 2023: $60.2 thousand | Fiscal year 2022: $85.3 thousand | Fiscal year 2021: $5.83 million | Fiscal year 2020: $4.27 million | Fiscal year 2019: $144.3 thousand | Fiscal year 2018: $226.7 thousand | Fiscal year 2017: $93.3 thousand | Fiscal year 2017: $204.9 thousand | Fiscal year 2016: $18.6 thousand | Fiscal year 2016: $173.5 thousand | Fiscal year 2015: $994.8 thousand | Fiscal year 2014: $0.00 | Fiscal year 2013: $618.00 | Fiscal year 2012: $13.4 thousand | Fiscal year 2011: $71.8 thousand | Fiscal year 2010: $2.8 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: